For Patients

Departments & Services

Division of Chemotherapy and Radiotherapy

The Division of Chemotherapy and Radiotherapy, West China Second Hospital of Sichuan University, formerly known as the Gynecological Oncology Chemotherapy and Biological Therapy Ward, was established in June 2006. With the strong support from the hospital and the obstetrics and gynecology department and hard work from all medical staff, we started from scratch,making great efforts to carry out various forms of chemotherapy, targeted therapy and immunotherapy for gynecological tumor patients and actively exploring precise diagnosis and treatment for gynecological malignancy. We are aiming to establish the prevention and control system for gynecological tumors, expand the specialized nursing service system, build non-vomiting wards, strengthen comprehensive management of cancer (including cancer pain, patient nutrition, thrombosis prevention, psychological counseling and traditional Chinese medicine), and finally expand the width and length of patients' lives.

In order to further promote the development of the discipline, the Division of Chemotherapy and Radiotherapy was established in December 2018 and moved to Jinjiang Campus. The addition of the radiotherapy marks the formation of a closed-loop diagnosis and treatment of gynecological malignant tumors in our hospital. The Division has set up special clinics such as genetic counseling and psychological counseling, and has set up a clinical trial phase I ward, aiming for a better integration with international and domestic multi-center clinical research. Our team has a good talent echelon, with rich theoretical knowledge, clinical practice experience and good scientific research background, which has laid a good foundation for the sustainable development of the Division. In the future, various tumor treatment such as hyperthermia, immunobiological therapy, and interventional therapy will be carried out gradually, featuring individualized comprehensive treatment for gynecological malignancy. These new treatments will make great contributions to improve treatment efficacy, patient survival and quality of life.